COVID-19 and the endocrine system: a comprehensive review on the theme

G Lisco, A De Tullio, A Stragapede… - Journal of clinical …, 2021 - mdpi.com
Background and aim. The review aimed to summarize advances in the topic of endocrine
diseases and coronavirus disease 2019 (COVID-19). Methods. Scientific and institutional …

[HTML][HTML] COVID-19 and obesity: overlap** of two pandemics

MA Gammone, N D'Orazio - Obesity Facts, 2021 - karger.com
Background: The coronavirus disease 2019 (COVID-19) pandemic has recently led to
worldwide research efforts to identify subjects at greater risk of develo** more severe …

[HTML][HTML] COVID-19 infections in gonads: consequences on fertility?

N Bechmann, U Maccio, R Kotb… - Hormone and …, 2022 - thieme-connect.com
COVID-19 may influence human fertility and sexuality in several ways. Different cell types in
gonads show a constitutive expression of angiotensin-converting enzyme 2 (ACE2) and …

Endocrine disorders and COVID-19

SH Oguz, BO Yildiz - Annual review of medicine, 2023 - annualreviews.org
The multifaceted interaction between coronavirus disease 2019 (COVID-19) and the
endocrine system has been a major area of scientific research over the past two years …

Burden of polycystic ovary syndrome in the Middle East and North Africa region, 1990–2019

K Motlagh Asghari, SA Nejadghaderi, M Alizadeh… - Scientific Reports, 2022 - nature.com
Polycystic ovary syndrome (PCOS) is one of the most important contributing factors to
infertility. In this study, we report the burden of PCOS by age and sociodemographic index …

Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review: PCOS and COVID-19 relationship

SF de Medeiros, MMW Yamamoto… - Reviews in Endocrine …, 2022 - Springer
This comprehensive review aimed to evaluate the relationship between SARS-CoV-2
infection (the cause of coronavirus disease 2019, or COVID-19) and the metabolic and …

Metformin is associated with reduced COVID-19 severity in patients with prediabetes

LE Chan, E Casiraghi, B Laraway, B Coleman… - Diabetes research and …, 2022 - Elsevier
Aims Studies suggest that metformin is associated with reduced COVID-19 severity in
individuals with diabetes compared to other antihyperglycemics. We assessed if metformin …

[HTML][HTML] Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 …

FA Cadegiani, A Goren, CG Wambier… - New microbes and new …, 2021 - Elsevier
In a prospective observational study (pre-AndroCoV Trial), the use of nitazoxanide,
ivermectin and hydroxychloroquine demonstrated unexpected improvements in COVID-19 …

[HTML][HTML] Final results of a randomized, placebo-controlled, two-arm, parallel clinical trial of proxalutamide for hospitalized COVID-19 patients: a multiregional, joint …

FA Cadegiani, RA Zimerman, DN Fonseca, MN Correia… - Cureus, 2021 - ncbi.nlm.nih.gov
Background The role of androgens on COVID-19 is well established. Proxalutamide is a
second-generation, non-steroidal antiandrogen (NSAA) with the highest antiandrogen …

Immunity, sex hormones, and environmental factors as determinants of COVID-19 disparity in women

S Rehman, V Ravinayagam, I Nahvi… - Frontiers in …, 2021 - frontiersin.org
The current coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome virus 2 (SARS-CoV-2), has resulted in a major global pandemic, causing extreme …